Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM, Lasho T.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163.
Myelodysplastic/myeloproliferative neoplasms.
Cazzola M, Malcovati L, Invernizzi R.
Hematology Am Soc Hematol Educ Program. 2011;2011:264-72. doi: 10.1182/asheducation-2011.1.264.
BCR-ABL gene variants.
Melo JV.
Baillieres Clin Haematol. 1997 Jun;10(2):203-22. doi: 10.1016/s0950-3536(97)80003-0.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH.
J Clin Oncol. 2018 Jan 20;36(3):231-237. doi: 10.1200/JCO.2017.74.7162. Epub 2017 Nov 1.
Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
Inokuchi K, Dan K.
J Nippon Med Sch. 2001 Aug;68(4):292-3. doi: 10.1272/jnms.68.292.
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.
Seong D, Kantarjian HM, Albitar M, Arlinghaus R, Xu J, Talpaz M, Rios MB, Guo JQ, O'Brien S, Siciliano M.
Ann Oncol. 1999 Aug;10(8):955-9. doi: 10.1023/a:1008349405763.
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S, Hasserjian RP, Hobbs G.
Curr Opin Hematol. 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565.
Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome.
Montefusco E, Alimena G, Lo Coco F, De Cuia MR, Wang YZ, Aloe Spiriti MA, Mancini F, Cedrone M, Mancini M, Mandelli F.
Ann Hematol. 1992 Jul;65(1):17-21. doi: 10.1007/BF01715120.
Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemia.
O'Hare T, Eide CA, Deininger MW.
J Natl Cancer Inst. 2008 Jul 2;100(13):908-9. doi: 10.1093/jnci/djn204. Epub 2008 Jun 24.
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ, Beran M.
Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832.
